Yes, it's refractory, which is not ideal but workable. Don't ever expect to see the word "refractory" in any press release, it's avoided and typically buried in technical reports.
Melanie knows already (or she's going to figure out) that the better path is not selling concentrate - but this will require higher capex however this will probably be justified as she grows the resource. POX is the likely solution to her problem.
Melanie still has a lot to do to and I'd like to see which path she's going down and see more met work optimisations to ascribe a better NPV to TTM.
The refractory nature will probably hold back the stock until it's better understood, well it should anyway. I keep it on watch for now.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)